/PRNewswire/ X-trodes, a bio-convergence company bringing wireless monitoring solutions to the home environment, today announced that the U.S. Food and Drug.
Novel Bluetooth-connected electrodes need no gel or suction cups and can be used comfortably at home to gather data while you sleep, and that’s just the start.
Israeli venture capital fund Welltech Ventures, which specializes in wellness technologies, has invested $1 million in X-trodes, a startup in the field of bio-convergence. The company, which has already raised $2 million to date, has developed an innovative technology to monitor and analyze physiological and neurological signals for patients at home.
“X-trodes’ solution is very exciting, and it will bring about a real revolution in the realm of healthcare and wellness,” explain Galit Horovitz and Amir Alroy, co-founders of Welltech Ventures. “The ability and the need to follow patients remotely, which will give them greater control over their bodies and their daily routines, has become a central issue that is even more sharply felt in the coronavirus era.”